Home/Greenwich LifeSciences/Dr. Francois-Clement Bidard
DF

Dr. Francois-Clement Bidard

Steering Committee Member

Greenwich LifeSciences

Therapeutic Areas

Greenwich LifeSciences Pipeline

DrugIndicationPhase
GLSI-100 (GP2 + GM-CSF)Prevention of recurrence in HLA-A*02+, HER2 3+ breast cancer (adjuvant setting)Phase III